NovaBiotics recognises that new, effective treatments are desperately needed to address these symptoms.

Our solution is Lynovex® (NM001), which is being developed to improve the quality & length of life of all CF patients – not just those with particular CFTR genotypes.

See the effect of Lynovex on cystic fibrosis sputum